EXASEXACT SCIENCES CORP

Nasdaq exactsciences.com


$ 45.29 $ 0.43 (0.96 %)    

Thursday, 30-May-2024 15:59:58 EDT
QQQ $ 454.82 $ -4.89 (-1.07 %)
DIA $ 398.57 $ -3.10 (-0.81 %)
SPY $ 530.36 $ -3.49 (-0.66 %)
TLT $ 91.26 $ 0.86 (0.97 %)
GLD $ 225.37 $ 0.41 (0.19 %)
$ 45.25
$ 45.14
$ 45.16 x 100
$ 45.29 x 100
$ 44.53 - $ 46.34
$ 43.59 - $ 100.77
2,570,095
na
8.35B
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 10-30-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-26-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 exact-sciences-says-it-demonstrates-continued-leadership-in-early-cancer-diagnosis-and-improved-health-outcomes-for-patients-with-multiple-data-presentations-at-american-society-of-clinical-oncology-annual-meeting

 Presentations will include new data confirming both the predictive and prognostic value of the Oncotype DX Breast Recurrence S...

 exact-sciences-announced-that-a-district-court-judge-denied-in-part-geneoscopys-defendant-motion-to-dismiss-a-patent-infringement-lawsuit-filed-by-exact-sciences-plaintiff-in-the-united-states-district-court-for-the-district-of-delaware

This ruling paves the way for Exact Sciences to seek relief for Geneoscopy's future infringement and false advertising.  ...

 btig-maintains-buy-on-exact-sciences-lowers-price-target-to-80

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $85 to $80.

 canaccord-genuity-maintains-buy-on-exact-sciences-lowers-price-target-to-85

Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $90...

 citigroup-maintains-buy-on-exact-sciences-lowers-price-target-to-80

Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 t...

 stocks-rebound-as-rising-jobless-claims-sustain-rate-cut-hopes-dollar-falls-gold-rallies-whats-driving-markets-thursday

Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising u...

 wall-street-stares-at-weaker-open-on-rate-anxiety-hopes-for-better-earnings-analyst-pencils-key-sp-500-support-level

Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.

 exact-sciences-stock-plunges-on-q1-earnings-what-you-need-to-know

Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $62...

 exact-sciences-q1-2024-gaap-eps-060-misses-048-estimate-sales-638000m-beat-627365m-estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0....

 stocks-falter-as-fed-signals-need-for-higher-for-longer-rates-uber-crashes-energy-sector-loses-ground-whats-driving-wednesdays-market

Wednesday witnessed a tempering of the bullish sentiment that had buoyed Wall Street in recent sessions, with major indices sho...

 wall-street-poised-for-muted-open-on-mixed-earnings-with-more-fed-speeches-in-store-analyst-sees-sp-500-crossing-late-march-high

U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more sp...

 will-earnings-cheer-continue-this-week-all-eyes-on-disney-palantir-robinhood-while-reddit-gears-up-for-debut-quarterly-report

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

 exact-sciences-appoints-aaron-bloomer-as-cfo-effective-may-15-2024

To help facilitate a smooth transition, Bloomer joins the company as executive vice president, finance, effective immediately, ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION